Workflow
competition
icon
Search documents
US and China Race for AI Supremacy
Bloomberg Technology· 2025-06-29 00:00
The number one factor that will define whether the United States or China wins this race is whose technology is most broadly adopted in the rest of the world. It's not just a matter of building more sophisticated models. Competition between the U.S. and China on AI is expanding to standards, governance, infrastructure and more.It's very hard to say how far ahead we are, but I would say not a huge amount of time. Any lead the U.S. has in eroding fast despite restrictions on exports of advanced semiconductor ...
Molson Coors Hurt By Fewer People Drinking Beer, Warns Analyst
Benzinga· 2025-06-27 18:55
Bank of America Securities analyst Bryan D. Spillane downgraded Molson Coors Beverage Company TAP from Buy to Neutral, lowering the price forecast from $65 to $50.In December, the analyst upgraded Molson Coors, expecting U.S. beer volumes to return to normal 2025 trends and the company’s market share to stabilize, which would help sustain margins and support a higher valuation through better cash flow visibility.However, that outlook hasn’t materialized, industry volumes continue to fall below historical le ...
X @Arkham
Arkham· 2025-06-27 17:18
ENDING SOON: $30,000 ARKHAM EXCHANGE TRADING COMPETITIONYou have until next Monday 30th June to complete ANY of the challenges below to earn a share of $30K & paid trips to PFL fights.1. Trading Challenge: 10,000 USDT Prize Pool2. Referral Challenge: 10,000 USDT Prize Pool3. New User Signup Challenge: 10,000 USDT Prize Pool4. Content Contest: 2 PFL Fight Tickets & Expenses for Travel/Stay ...
X @Tesla Owners Silicon Valley
Elon Musk “It would be great to have other companies working on full rocket reusability as well. Competition is a good thing.”https://t.co/jqJm32P7dP ...
No Trump Card: EU Says Tech Crackdown Isn't a US Trade Tactic
Bloomberg Television· 2025-06-26 08:44
So I'd like just to begin there in terms of what you have unveiled here, do you think that this gives now the European Union a real chance to compete with some of these very sort of heavily government backed industries in China, for example, and in the United States with the Inflation Reduction Act. Hello. Good morning.So it's not against anyone, but it is just to assure that it is not that we are reliable, predictable and stable continent. It is that we are an attractive continent and that we, the Member S ...
Why Shares in Novo Nordisk Lost Weight Today
The Motley Fool· 2025-06-25 19:09
Core Viewpoint - Novo Nordisk's shares fell by 4% following the termination of its partnership with Hims & Hers, which has led to escalating fallout from the decision [1] Group 1: Partnership Termination - Novo Nordisk terminated its partnership with Hims & Hers, citing non-compliance with laws regarding the mass sales of compounded drugs and deceptive marketing practices [2] - The disagreement centers around the weight loss drug Wegovy, with Novo Nordisk claiming Hims & Hers failed to stop the mass sales of copycat versions [3] Group 2: Management Response - Hims & Hers CEO Andrew Dudum responded by suggesting that Novo Nordisk was pressuring his company to promote Wegovy, indicating a strained relationship [3] - Dudum also mentioned that Novo Nordisk is experiencing significant market share loss and management turmoil, implying financial strain [4] Group 3: Market Implications - The termination of the partnership and subsequent comments highlight competitive threats to Wegovy, particularly from Eli Lilly's Zepbound [6] - Despite the competitive landscape, Wegovy sales are reportedly growing at an impressive rate, with an 85% increase in the first quarter [6]
Will New Drugs Enable BMY to Offset the Impact of Generic Competition?
ZACKS· 2025-06-25 15:05
Key Takeaways BMY faces generic pressure on key drugs like Revlimid and Pomalyst, plus Medicare Part D headwinds. New drugs like Reblozyl, Opdualag and Breyanzi are driving growth amid strong uptake and new approvals. BMY trades at 7.34x forward earnings, below its average and the broader large-cap pharma industry.Bristol Myers (BMY) depends on newer drugs like Opdualag, Reblozyl and Breyanzi to stabilize its revenue base as its legacy drugs face generic competition.Legacy Portfolio is adversely impacted ...
X @BREAD | ∑:
BREAD | ∑:· 2025-06-25 10:15
The problem was/is not lack of talent.The problem is a future state that contains both of these words while expecting a graceful outcome:▸ "competing"▸ "coordination"Client teams pull this off somewhat because they have to. L2 teams have no obligation to coordinate.venture anthropologist (@0xBalloonLover):ethereum's strategy of punting the roadmap to a bunch of different competing L2 teams only makes sense if there was an abundance of talentbut the talent is pathetic so what's resulted is a bunch of coordin ...
Union Pacific (UNP) Conference Transcript
2025-06-24 16:00
Union Pacific (UNP) Conference June 24, 2025 11:00 AM ET Speaker0 Ladies and gentlemen, the program is about to begin. A reminder that this webcast presentation is for Bank of America and Union Pacific clients only. If you are a member or representative of the press or media, please disconnect now. At this time, it is my pleasure to turn the program over to your host from Bank of America, Ken Hoexter. Speaker1 Great. Good morning. Thanks, Paul. I am Ken Hoexter, BofA's air freight and surface transportation ...
UK may require Google to give users alternative search options and rank its results ‘more fairly'
TechCrunch· 2025-06-24 14:05
The U.K.’s competition regulator said on Tuesday it is considering a new market designation for Google that would require the search giant to provide alternative search options to users, rank search results “more fairly,” and offer greater control to publishers over how their content is used in search and AI Overviews.Under the new Digital Markets Competition Regime that went into force earlier this year, the U.K.’s Competition and Markets Authority (CMA) said it is launching a consultation on whether to de ...